The Indian Pharmaceutical Market to 2011 Competitive dynamics and major players

Traditionally, the Indian pharmaceutical industry has been characterized by a core competency in generics’ manufacturing and relatively immature capabilities in R&D. This outlook has evolved substantially since the 1990s and Indian companies have been making investments towards expanding drug discovery and development capabilities. The acceptance of patent laws and the rise of contract manufacturing have led to the diversification of revenue streams, enabling Indian pharma companies to experience high market growth. ‘The Indian Pharmaceutical Market to 2011’ provides a detailed analysis of the leading players and discusses how they are planning to sustain growth over the next five years. For each company, this report analyzes current and future therapeutic focus, sales growth, key pipeline products and future growth prospects. This report will help you to identify the critical success factors that have driven company growth, evaluate diversification opportunities and assess the future potential of each company’s R&D portfolio over the next five years.

Published: July 2007

PDF Format
Table of Contents
Table of Contents (PDF)
Price: $2,875.00 / GBP1,495.00